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Abstract. 
 
Adducin is a membrane skeletal protein that 
binds to actin ﬁlaments (F-actin) and thereby promotes 
the association of spectrin with F-actin to form a spec-
trin-actin meshwork beneath plasma membranes such 
as rufﬂing membranes. Rho-associated kinase (Rho-
 
kinase), which is activated by the small guanosine triphos-
phatase Rho, phosphorylates 
 
a
 
-adducin and thereby 
enhances the F-actin–binding activity of 
 
a
 
-adducin in 
vitro. Here we identiﬁed the sites of phosphorylation of 
 
a
 
-adducin by Rho-kinase as Thr445 and Thr480. We 
prepared antibody that speciﬁcally recognized 
 
a
 
-addu-
cin phosphorylated at Thr445, and found by use of this 
antibody that Rho-kinase phosphorylated 
 
a
 
-adducin at 
Thr445 in COS7 cells in a Rho-dependent manner. 
Phosphorylated 
 
a
 
-adducin accumulated in the mem-
brane rufﬂing area of Madin-Darby canine kidney 
(MDCK) epithelial cells and the leading edge of scat-
tering cells during the action of tetradecanoylphorbol-
13-acetate (TPA) or hepatocyte growth factor (HGF). 
The microinjection of 
 
Botulinum
 
 C3 ADP-ribosyl-
transferase, dominant negative Rho-kinase, or
 
a
 
-adducin
 
T445A,T480A
 
 (substitution of Thr445 and
Thr480 by Ala) inhibited the TPA-induced membrane 
rufﬂing in MDCK cells and wound-induced migra-
tion in NRK49F cells. 
 
a
 
-Adducin
 
T445D,T480D
 
 (substi-
tution of Thr445 and Thr480 by Asp), but not
 
a
 
-adducin
 
T445A,T480A
 
, counteracted the inhibitory
effect of the dominant negative Rho-kinase on the 
TPA-induced membrane rufﬂing in MDCK cells. Taken 
together, these results indicate that Rho-kinase phos-
phorylates 
 
a
 
-adducin downstream of Rho in vivo, and 
that the phosphorylation of adducin by Rho-kinase 
plays a crucial role in the regulation of membrane ruf-
ﬂing and cell motility.
Key words: Rho • Rho-kinase • adducin • membrane 
rufﬂing • cell motility
 
M
 
EMBRANE
 
 ruffling, a dynamically fluctuating move-
ment of protrusion consisting of filopodia and
lamellipodia, is rapidly induced in response to
certain extracellular signals and is also induced in the lead-
ing edges of motile cells (Stossel, 1993; Lauffenburger and
Horwitz, 1996; Mitchison and Cramer, 1996; Welch et al.,
1997). Membrane ruffling is thought to be important for
cell motility (Mitchison and Cramer, 1996). The small GTP-
ase Rho regulates the formation of actin stress fibers and
focal adhesions (Ridley and Hall, 1992, 1994; Hall, 1998),
membrane ruffling (Nishiyama et al., 1994; Takaishi et al.,
1995) and cell motility (Takaishi et al., 1993, 1994) in cer-
tain types of cells, cell morphology (Paterson et al., 1990),
cell aggregation (Tominaga et al., 1993), smooth muscle
contraction (Hirata et al., 1992; Gong et al., 1996), neurite
retraction in neuronal cells (Nishiki et al., 1990; Jalink et al.,
1994), the formation of microvilli (Shaw et al., 1998), and
cytokinesis (Kishi et al., 1993; Mabuchi et al., 1993). Rho
exerts its biological functions through interaction with spe-
cific targets (Van Aelst and D’Souza-Schorey, 1997). Sev-
eral targets of Rho have been identified, including protein
kinase N (PKN)
 
1
 
 (Amano et al., 1996b; Watanabe et al.,
1996), Rho-kinase/ROK/ROCK (Leung et al., 1995; Ish-
izaki et al., 1996; Matsui et al., 1996), the myosin-binding
subunit (MBS) of myosin phosphatase (Kimura et al.,
1996), p140mDia (Watanabe et al., 1997), citron (Madaule
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1. 
 
Abbreviations used in this paper:
 
 
 
a
 
-adducin-AA, 
 
a
 
-adducin with substi-
tution of Thr445 and Thr480 by Ala; 
 
a
 
-adducin-DD, 
 
a
 
-adducin with sub-
stitution of Thr445 and Thr480 by Asp; CAT, catalytic domain; ERM,
ezrin/radixin/moesin; GST, glutathione-
 
S
 
-transferase; HA, hemagglutinin;
HGF, hepatocyte growth factor; LPA, lysophosphatidic acid; MBP, mal-
tose-binding protein; MBS, myosin-binding subunit; MLC, myosin light
chain; PH, pleckstrin-homology domain; PK, protein kinase; RB, Rho-
binding domain; TPA, tetradecanoylphorbol-13-acetate. 
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et al., 1995), citron-kinase (Madaule et al., 1998), rhophi-
lin, rhotekin (Reid et al., 1996), and kv1.2 (Cachero et al.,
1998). Rho-kinase, which is activated by Rho, regulates
the phosphorylation of myosin light chain (MLC) by the
direct phosphorylation of MLC (Amano et al., 1996a) and
by the inactivation of myosin phosphatase through the
phosphorylation of MBS (Kimura et al., 1996). Rho-kinase
regulates the formation of stress fibers and focal adhesions
(Leung et al., 1996; Amano et al., 1997; Ishizaki et al.,
1997), smooth muscle contraction (Kureishi et al., 1997),
and neurite retraction (Amano et al., 1998; Hirose et al.,
1998; Katoh et al., 1998) through the phosphorylation of
MLC. Rho-kinase also phosphorylates the ezrin/radixin/
moesin (ERM) family proteins (Matsui et al., 1998) and
then regulates the formation of microvilli (Oshiro et al.,
1998). However, it remains to be clarified how Rho regu-
lates membrane ruffling and cell motility.
Recently, we identified adducin as an MBS-binding pro-
tein and a substrate of Rho-kinase in vitro (Kimura et al.,
1998). Adducin is a membrane skeletal protein that binds
to the fast growing ends (Kuhlman et al., 1996; Li et al.,
1998) and the sides (Mische et al., 1987) of actin filaments
(F-actin), and thereby promotes the association of spectrin
with F-actin to form a spectrin-actin meshwork beneath
plasma membranes (Gardner and Bennett, 1987; Bennett
et al., 1988). Adducin is composed of either 
 
a
 
 and 
 
b
 
, or 
 
a
 
and 
 
g
 
 subunits which are closely related in amino acid
sequence and domain organization (Gardner and Ben-
nett, 1986; Bennett et al., 1988; Dong et al., 1995). Each
adducin subunit has three distinct domains: an amino-
terminal head domain, a neck domain, and a carboxy-ter-
minal tail domain (Joshi and Bennett, 1990; Joshi et al.,
1991; Dong et al., 1995). The tail domain has a domain
called the myristoylated alanine–rich C kinase substrate
(MARCKS)-related domain, which contains a highly basic
stretch and binds to calmodulin (Joshi et al., 1991; Dong et
al., 1995; Matsuoka et al., 1996). Adducin is also a sub-
strate for PKC and PKA (Palfrey and Waseem, 1985; Kaiser
et al., 1989; Dong et al., 1995). The phosphorylation of ad-
ducin by PKA reduces the activity of adducin to associate
with F-actin and spectrin–F-actin complexes and to recruit
spectrin to F-actin (Matsuoka et al., 1996). The phosphor-
ylation of adducin by PKC also inhibits activity of adducin
in binding to F-actin and recruiting spectrin to F-actin
(Matsuoka et al., 1998). On the other hand, the phosphor-
ylation of adducin by Rho-kinase results in the interaction
of adducin with F-actin in vitro (Kimura et al., 1998).
In this study, we identified the sites of phosphorylation
of 
 
a
 
-adducin by Rho-kinase as Thr445 and Thr480, and
prepared antibody that specifically recognized 
 
a
 
-adducin
phosphorylated at Thr445 to elucidate the functions of
 
a
 
-adducin phosphorylated by Rho-kinase. We found that
 
a
 
-adducin was phosphorylated at Thr445 via the Rho/
Rho-kinase pathway in intact cells, and that the phos-
phorylation of 
 
a
 
-adducin by Rho-kinase plays a crucial
role in membrane ruffling and cell motility.
 
Materials and Methods
 
Materials and Chemicals
 
MDCK cells were kindly provided by Dr. S. Tsukita (Kyoto University,
 
Kyoto, Japan). NRK49F cells were purchased from American Type Cul-
ture Collection. pEF-BOS-HA-RhoA
 
V14
 
, RhoA
 
N19
 
,
 
 
 
Rac1
 
V12
 
, Cdc42
 
V12
 
,
pEF-BOS-myc-Rho-kinase (full-length, 6–1388 amino acids [aa]), Rho-
binding domain (RB; 941–1075 aa), RB/PH (TT) (941–1388 aa), and CAT
(the catalytic domain of Rho-kinase, 6–553 aa) were constructed as de-
scribed (Kuroda et al., 1996; Matsui et al., 1996; Amano et al., 1997, 1998).
pcDSR
 
a
 
-PKC
 
b
 
 lacking C1 domain at positions 6–159 aa was constructed
as described (Kaibuchi et al., 1989). pQE-rat 
 
g
 
-adducin fragment (319–671
aa; 35H fragment-4D) was kindly provided by Dr. S. Jaken (University of
Vermont,
 
 
 
Burlington, VT), and 6 X His-tagged 
 
g
 
-adducin fragment was
produced and purified as described (Dong et al., 1995). The expression
plasmid of C3 transferase (pGEX-C3) was kindly provided by Dr. A. Hall
(University College London, London, UK), and C3 was produced and
purified as described (Fukata et al., 1998). Glutathione-
 
S
 
-transferase
(GST)-RB was produced and purified from 
 
Escherichia coli 
 
as described
(Amano et al., 1997). GST-CAT was produced and purified from Sf9 cells
as described previously (Matsuura et al., 1987; Amano et al., 1996a).
Rac1
 
N17
 
 was produced and purified from 
 
E
 
.
 
 coli
 
 as described (Kuroda et
al., 1996). Anti-hemagglutinin (HA) monoclonal Ab (12CA5) was pur-
chased from Boehringer Mannheim. [
 
g
 
-
 
32
 
P]ATP was purchased from Am-
ersham Corp. All materials used in the nucleic acid study were purchased
from Takara Shuzo Corp. Other materials and chemicals were obtained
from commercial sources.
 
Plasmid Constructs
 
The cDNA encoding human 
 
a
 
-adducin (1–737 aa; Joshi et al., 1991) was
inserted into the KpnI site of pEF-BOS-HA, into the KpnI site of
pAcYM1-HA to obtain recombinant 
 
a
 
-adducin by the use of a baculovi-
rus system, and into the BamHI site of pGEX-2T. The cDNA encoding
human 
 
b
 
-adducin (1–726 aa; Joshi et al., 1991) was also inserted into the
KpnI site of pAcYM1-HA. The cDNAs of 
 
a
 
-adducin
 
T445A,T480A
 
 (AA) and
 
a
 
-adducin
 
T445D,T480D
 
 (DD), which were substituted for Thr at both 445 and
480 amino acid residues by Ala or Asp, were generated with the use of a
site-directed mutagenesis kit (Stratagene), and subcloned into pEF-BOS-
HA, pAcYM1-HA, and pGEX-2T. The cDNAs of 
 
a
 
-adducin
 
T445A
 
 and 
 
a
 
-addu-
cin
 
T480A
 
 were also generated as above and subcloned into pGEX-2T.
 
Protein Purification
 
RB/PH (TT) (Amano et al., 1998) was expressed as a maltose-binding
protein (MBP) fusion protein in 
 
E
 
.
 
 coli
 
 and purified. GST-
 
a
 
-adducin,
GST-
 
a
 
-adducin-AA, GST-
 
a
 
-adducin
 
T445A
 
, and GST-
 
a
 
-adducin
 
T480A
 
 were
produced and purified from 
 
E
 
.
 
 coli
 
. HA-
 
a
 
-adducin, HA-
 
b
 
-adducin, HA-
 
a
 
-adducin-AA, and HA-
 
a
 
-adducin-DD were produced in Sf9 cells. The
cells expressing HA-
 
a
 
-adducin were suspended in homogenizing buffer
(20 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 mM DTT, 10 
 
m
 
M A-PMSF, 10
 
m
 
g/ml leupeptin). The suspension was sonicated and centrifuged at
100,000 
 
g
 
 for 1 h at 4
 
8
 
C. The supernatant was applied onto a Mono Q col-
umn (Pharmacia LKB Biotechnology) which had been equilibrated with
buffer A (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM DTT). The col-
umn was then washed, and the proteins were eluted with a linear concen-
tration gradient of NaCl (0–600 mM) in buffer A. HA-
 
a
 
-adducin was
eluted with 
 
z
 
200 mM NaCl and purified to near homogeneity. HA-
 
b
 
-adducin, HA-
 
a
 
-adducin-AA, and HA-
 
a
 
-adducin-DD were prepared as
HA-
 
a
 
-adducin.
 
Determination of Phosphorylation Sites of 
 
a
 
-Adducin 
by Rho-Kinase
 
HA-
 
a
 
-adducin (70 
 
m
 
g of protein) was phosphorylated with GST-CAT
(120 ng of protein) in 2 ml of kinase buffer (50 mM Tris-HCl, pH 7.5, 5 mM
MgCl
 
2
 
, 1 mM EDTA, 1 mM EGTA, 1 mM DTT) containing 100 
 
m
 
M
[
 
g
 
-
 
32
 
P]ATP for 1 h at 30
 
8
 
C, and the reaction product was digested with
 
Achromobacter
 
 protease-1 (AP-1) at 37
 
8
 
C for 20 h. The obtained pep-
tides were applied onto a C18 reverse-phase column (4.6 
 
3
 
 250 mm;
Shiseido, Japan) and eluted with a linear gradient of 0–48% acetonitrile
for 100 min at a flow rate of 1.0 ml/min by HPLC (System Gold, Beck-
man). The radioactive peaks were separated and phosphoamino acid se-
quencing was carried out with a peptide sequencer (PPSQ-10; Shimadzu,
Japan) as described (Bodwell et al., 1991). The fractions obtained from
each Edoman degradation cycle were measured for 
 
32
 
P in a Beckman liq-
uid scintillation counter. 
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Production of Site- and Phosphorylation State–specific 
Antibody for 
 
a
 
-Adducin
 
The phosphopeptide Cys-Gln
 
440
 
-Gln-Arg-Glu-Lys-phospho-Thr-Arg-Trp-
Leu-Asn-Ser
 
450
 
 was chemically synthesized as an antigen by Peptide Insti-
tute Inc. Rabbit polyclonal antibody (anti-pT445) was raised against the
phosphopeptide and affinity purified as described (Inagaki et al., 1997).
To examine the specificity of anti-pT445, equal amounts of HA-
 
a
 
-adducin
(40 fmol) with various ratios between phosphorylated and nonphosphory-
lated proteins were subjected to SDS-PAGE. HA-
 
a
 
-adducin-AA (40
fmol) was incubated in kinase buffer containing GST-CAT and ATP, and
subjected to SDS-PAGE. The amount of phosphates incorporated into
HA-
 
a
 
-adducin was simultaneously determined by [
 
g
 
-
 
32
 
P]ATP. Immuno-
blot analysis was then performed with anti-pT445, anti-pT445 which was
preincubated with a 100-fold amount of antigen-phosphopeptide, and
anti-HA Ab. For some experiments, HA-
 
a
 
-adducin, HA-
 
b
 
-adducin, or 6 X
His-
 
g
 
-adducin fragment was separately phosphorylated with GST-CAT,
and 40 fmol (as 
 
32
 
P-incorporated amount) of phosphorylated proteins was
subjected to immunoblot analysis with anti-pT445.
 
Cell Culture
 
MDCK cells and NIH3T3 cells were maintained in DMEM containing
10% calf serum, streptomycin, and penicillin. COS7 cells were maintained
in DMEM containing 10% FBS, streptomycin, and penicillin. NRK49F
cells were maintained in DMEM containing 5% calf serum and 1% nones-
sential amino acids. To obtain MDCK cells stably expressing HA-
 
a
 
-addu-
cin, MDCK cells were transfected with pEF-BOS-HA-
 
a
 
-adducin along
with pSVIISR
 
a
 
 vector containing the neomycin resistance gene using Li-
pofectamine (GIBCO BRL) as described (Kuroda et al., 1998), and neo-
mycin-resistant clones were selected.
 
Detection of Thr445-phosphorylated 
 
a
 
-Adducin in 
Intact Cells
 
The transfection of plasmids into COS7 cells was carried out by the stan-
dard DEAE-dextran method. COS7 cells were cotransfected with pEF-
BOS-HA-
 
a
 
-adducin and pEF-BOS-vector, pEF-BOS encoding HA-
Rac1
 
V12
 
, HA-Cdc42
 
V12
 
, HA-RhoA
 
V14
 
, HA-RhoA
 
N19
 
, myc-Rho-kinase
(full-length), HA-RhoA
 
V14
 
 and myc-Rho-kinase (full-length), HA-
RhoA
 
V14
 
 and myc-RB, HA-RhoA
 
V14
 
 and myc-RB/PH (TT), myc-CAT, or
pcDSR
 
a
 
-PKC
 
b
 
. Separately, COS7 cells were cotransfected with pEF-
BOS-HA-
 
a
 
-adducin-AA and myc-CAT. After a 24-h incubation, the
transfected cells were incubated in serum-free medium for 24 h. The cells
were treated with 10% (wt/vol) trichloroacetic acid. The resulting precipi-
tates were subjected to immunoblot analysis using anti-HA Ab and anti-
pT445. MDCK cells stably expressing HA-
 
a
 
-adducin were incubated in
the absence or the presence of tetradecanoylphorbol-13-acetate (TPA)
for 15 min followed by incubation in the presence of 0.1 
 
m
 
M calyculin A
for 10 min. The cells were then treated as COS7 cells and subjected to im-
munoblot analysis.
 
Immunofluorescence Analysis
MDCK cells were deprived of serum for 24 h and incubated in DMEM
containing 200 nM TPA or 50 pM recombinant human hepatocyte growth
factor (HGF; Calbiochem) for 15 min at 378C. For cell scattering, the cells
were not deprived of serum and incubated in DMEM containing 5% calf
serum and 200 nM TPA for 2 h. The cells were fixed with 3.0% formalde-
hyde in PBS for 10 min and treated with PBS containing 0.2% Triton
X-100 for 10 min. Phosphorylated adducin and F-actin were doubly
stained with anti-pT445 and TRITC-phalloidin. For anti-pT445, the cells
were then labeled with FITC-conjugated anti–rabbit Ig Ab. For a double
immunofluorescence study, the clone stably expressing HA-a-adducin
was stimulated as described above. Phosphorylated adducin and HA-
a-adducin were doubly stained with anti-pT445 and anti-HA Ab. The
cells were then labeled with FITC-conjugated anti–rabbit Ig Ab and Texas
red–conjugated anti–mouse Ig Ab. The cells were examined using a Zeiss
Axiophot microscope or a confocal microscope (Carl Zeiss).
Microinjection
MDCK cells were seeded at a density of 2.5 3 103 cells per 13-mm cover
glass in 60-mm tissue culture dishes and incubated for 8 h. Then, the cells
were deprived of serum for 24 h. For microinjection, proteins were con-
centrated and during the concentration the buffer was replaced by micro-
injection buffer (20 mM Tris-HCl, pH 7.4, 20 mM NaCl, 1 mM MgCl2,
0.1 mM EDTA, 5 mM 2-mercaptoethanol). The indicated proteins were
microinjected along with a marker protein (rabbit or mouse IgG at 0.5
mg/ml) into the cytoplasm of cells. Using microcapillaries (tip diameter is
0.5 mm), z3 3 10214 liter of each protein was microinjected by one injec-
tion. When C3 was microinjected at 0.1 mg/ml, the injected amount per
cell was z3 3 10215 g (the intracellular concentration was estimated to be
z0.15 mM). When HA-a-adducin mutants were microinjected at 5.0 mg/ml,
the injected amount per cell was z150 3 10215 g (the intracellular concen-
tration was estimated to be z2.0 mM, and it seemed to be much higher
than the level of endogenous a-adducin). 30 min after the microinjection,
the cells were incubated in DMEM containing 200 nM TPA for 15 min at
378C. The cells were then fixed and stained with anti-pT445 or TRITC-
phalloidin as described above.
Wound Healing Assay
Cell migration assay using a wound healing model was performed as de-
scribed previously (Santos et al., 1997). The confluent monolayer of the
cells was scraped with a white chip. Soon after wounding, the medium was
changed and indicated recombinant proteins were microinjected along
with a marker protein (rabbit IgG, 1.0 mg/ml) into the cytoplasm of only
the cells along the wound edge as described above. The original wound
edge was determined by taking photographs soon after the cells were
wounded and microinjected. After 6 h, the cells were then stained with
TRITC-phalloidin, and the cells that moved (.20 mm) from the original
wound edge were counted by taking photographs of the same fields as the
original photograph.
Other Procedures
SDS-PAGE was performed as described (Laemmli, 1970). Protein con-
centrations were determined with BSA as the reference protein as de-
scribed (Bradford, 1976).
Results
Determination of the Sites of Phosphorylation of
a-Adducin by Rho-Kinase
We first determined the sites of phosphorylation of human
a-adducin by Rho-kinase as follows. HA-tagged a-addu-
cin, which was phosphorylated by Rho-kinase in the pres-
ence of [g-32P]ATP, was digested with AP-I and subjected
to reverse-phase HPLC as described (Shirataki et al.,
1993). Two major radioactive peaks (named peak 1 and 2,
respectively) were obtained (Fig. 1 A) and their amino
acid sequences were determined. The sequence obtained
from peak 1 was TRWLNSGRGDEASEEGQNGSSPK,
corresponding to residues 445–467 of human a-adducin,
and Thr445 turned out to be the phosphorylation site for
Rho-kinase (Fig. 1 B, panel a). The sequence obtained
from peak 2 was EDGHRTSTSAVPNLFVPLNTNPK,
corresponding to residues 475–497 of human a-adducin,
and Thr480 turned out to be the phosphorylation site for
Rho-kinase (Fig. 1 B, panel b). Both phosphorylation sites
were in the neck domain of a-adducin, and were different
from previously identified sites of phosphorylation by
PKA (Ser408, Ser436, Ser481, and Ser726) and by PKC
(Ser726) (Matsuoka et al., 1996) (Fig. 1 C). When GST-
a-adducinT445A or GST-a-adducinT480A (substitution of
Thr445 or Thr480 by Ala) was phosphorylated by Rho-
kinase, GST-a-adducinT480A was more efficiently phosphor-
ylated by Rho-kinase than was GST-a-adducinT445A (Fig. 1
D). This result is apparently inconsistent with the observa-
tion that the radioactivity of peak 1 containing Thr445 is
lower than that of peak 2 containing Thr480 in the HPLCThe Journal of Cell Biology, Volume 145, 1999 350
analysis (Fig. 1 A). This may be due to the different recov-
ery of each peptide during separation by HPLC. Taken to-
gether, these results suggest that Thr445 is a preferential
site of phosphorylation by Rho-kinase in vitro.
Production and Characterization of the Site- and 
Phosphorylation State–specific Antibody for a-Adducin
An antibody that recognizes the phosphorylated state of a
substrate at a specific site is a useful tool with which to
evaluate site-specific phosphorylation in vivo and to visu-
alize the cellular distribution of the protein phosphory-
lated at a specific site (Inagaki et al., 1997). We prepared
and affinity purified the polyclonal antibody that recog-
nized the Thr445-phosphorylated a-adducin (anti-pT445),
against the synthetic phosphopeptide Cys-Gln-Gln-Arg-
Glu-Lys-phospho-Thr445-Arg-Trp-Leu-Asn-Ser. An immu-
noblot analysis revealed that anti-pT445 specifically bound
to HA-a-adducin phosphorylated by Rho-kinase in a
dose-dependent manner, but not to nonphosphorylated
Figure 1. Determination of sites of phosphorylation of a-adducin by
Rho-kinase. (A) Reverse-phase HPLC for AP-1 fragments of a-adducin
phosphorylated by Rho-kinase was carried out under the conditions de-
scribed in Materials and Methods. CH3CN, acetonitrile. (B) Amino acid se-
quences of phosphopeptides derived from a-adducin phosphorylated by
Rho-kinase. The radioactive peaks 1 (panel a) and 2 (panel b) were sepa-
rated. Phosphoamino acid sequencing of each peak was carried out with a
peptide sequencer, and the fractions obtained from each Edoman degrada-
tion cycle were measured for 32P in a liquid scintillation counter. (C) Struc-
ture and phosphorylation sites of a-adducin. A model for a-adducin
based on Matsuoka et al. (1996) is presented. The phosphorylation sites
of a-adducin for PKA, PKC, and Rho-kinase are presented. (D) Pref-
erential phosphorylation of a-adducin at Thr445 by Rho-kinase in
vitro. GST-a-adducin (WT, circles), GST-a-adducin-AA (AA, X), GST-
a-adducinT445A (T445A, triangles), and GST-a-adducinT480A (T480A,
squares) were phosphorylated by GST-CAT for various periods. Data are
means 6 SEM of triplicate determinations.Fukata et al. Adducin Phosphorylation Downstream of Rho 351
HA-a-adducin or HA-a-adducinT445A,T480A (substitution of
Thr445 and Thr480 by Ala; HA-a-adducin-AA) incubated
with Rho-kinase and ATP (Fig. 2 A). HA-a-adducin,
which was phosphorylated by PKC or PKN at levels simi-
lar to that by Rho-kinase, was not recognized by anti-
pT445 (data not shown). The binding of anti-pT445 to
a-adducin phosphorylated by Rho-kinase was neutralized
by preincubation of the antibody with the antigen phos-
phopeptide. Rho-kinase phosphorylated b- and g-adducin
in vitro as well (Fig. 2 B). Neither b- nor g-adducin phos-
phorylated by Rho-kinase was recognized by anti-pT445
(Fig. 2 B). These results indicate that anti-pT445 specifi-
cally recognizes only a-adducin phosphorylated at Thr445.
Rho/Rho-Kinase–dependent Phosphorylation of
a-Adducin in COS7 Cells
We examined whether a-adducin was phosphorylated via
the Rho/Rho-kinase pathway in COS7 cells by immuno-
blot analysis with anti-pT445. cDNA of HA-a-adducin
was cotransfected with plasmids carrying the cDNA of
dominant active Rho family members, or dominant active
or negative Rho-kinase (Fig. 3). HA-a-adducin was almost
equally expressed in all the HA-a-adducin–transfected
cells. a-Adducin phosphorylated at Thr445 was undetect-
able in serum-starved COS7 cells expressing HA-a-addu-
cin alone. The expression of dominant active RhoA
(RhoAV14), a RhoA mutant that is defective in GTPase ac-
tivity and thought to be constitutively the GTP-bound
form in the cells, induced a small increment of the a-addu-
cin phosphorylation at Thr445, whereas the expression of
dominant negative RhoA (RhoAN19), a RhoA mutant that
preferentially binds GDP rather than GTP and is thought
to be constitutively the GDP-bound form in the cells, had
minimal effects. Although the exact reason for the mini-
mal increase in phosphorylated a-adducin in COS7 cells
expressing RhoAN19 is unknown, it is likely that the over-
expression of GDP-bound RhoAN19 induced the phos-
phorylation of a-adducin to a minimal extent because
GDP · Rho also activates Rho-kinase in vitro to a small ex-
tent as described (Matsui et al., 1996). Dominant active
Rac1 (Rac1V12) or dominant active Cdc42 (Cdc42V12) had
no effects. Under the conditions, RhoAV14, RhoAN19,
Rac1V12, and Cdc42V12 were almost equally expressed
(data not shown). The expression of Rho-kinase induced
the a-adducin phosphorylation to some extent. By the co-
expression of RhoAV14 and Rho-kinase, the a-adducin
phosphorylation was further enhanced. Rho-kinase is
composed of catalytic (CAT), coiled-coil (COIL), Rho-
binding (RB), and pleckstrin-homology (PH) domains
(Matsui et al., 1996). RB (941–1075 aa) binds to Rho and
inhibits the Rho-dependent Rho-kinase activity in vitro
and in vivo (Amano et al., 1997). RB/PH (TT) (941–1388
aa), which is the carboxy-terminal portion of Rho-kinase
and encompasses the RB and PH domains, has point mu-
tations in the RB domain and does not bind to Rho
(Fujisawa et al., 1996; Leung et al., 1996; Amano et al.,
1998). RB/PH (TT) inhibits the lysophosphatidic acid
(LPA)-induced stress fiber formation in fibroblasts and
neurite retraction in neuroblastoma cells (Amano et al.,
1998), suggesting that RB/PH (TT) serves as the dominant
negative form of Rho-kinase. Recently, we found that RB/
PH (TT) interacted with the catalytic domain of Rho-
kinase and thereby inhibited the Rho-kinase activity in
vitro without titrating out Rho (Amano, M., K. Chihara,
N. Nakamura, T. Kaneko, Y. Matsuura, and K. Kaibuchi,
manuscript submitted for publication). We further found
that RB/PH (TT) had no effect on catalytic activity of
PKN or myotonic dystrophy kinase-related Cdc42-bind-
ing kinase (MRCK), which is identified as a target of
Cdc42 and is homologous to Rho-kinase within the kinase
domain (Leung et al., 1998), in vitro (Amano, M., K. Chi-
hara, N. Nakamura, T. Kaneko, Y. Matsuura, and K.
Kaibuchi, manuscript submitted for publication). RB/PH
(TT) inhibited the Rho-kinase–induced stress fiber, but
not MRCK-induced stress fiber (Leung et al., 1998) in fi-
Figure 2. Specificity of anti-pT445. (A) HA-a-adducin (40 fmol),
containing the indicated amounts of HA-a-adducin phosphory-
lated by Rho-kinase, and HA-a-adducin-AA (40 fmol) phosphor-
ylated by Rho-kinase were subjected to immunoblot analysis
with anti-pT445, anti-pT445 preincubated with a 100-fold amount
of antigen-phosphopeptide, and anti-HA antibody. The amount
of phosphates incorporated into HA-a-adducin was simulta-
neously determined by [g-32P]ATP. (B) Anti-pT445 reacts with
only a-adducin phosphorylated by Rho-kinase. HA-a-adducin,
HA-b-adducin, or 6 X His-g-adducin fragment (319–671 aa) was
separately phosphorylated with GST-CAT, resolved by SDS-
PAGE, and visualized by an image analyzer (right). 40 fmol (as
32P-incorporated amount) of phosphorylated proteins was sub-
jected to immunoblot analysis with anti-pT445 (left). From the
top, arrows indicate the positions of the intact HA-a-adducin,
HA-b-adducin, or 6 X His-g-adducin, respectively. Anti-pT445
also bound to the degradation products of HA-a-adducin. The
results are representative of three independent experiments.The Journal of Cell Biology, Volume 145, 1999 352
broblasts (Amano, M., K. Chihara, N. Nakamura, T.
Kaneko, Y. Matsuura, and K. Kaibuchi, manuscript sub-
mitted for publication). These observations indicate that
RB/PH (TT) more specifically inhibits the Rho-kinase ac-
tivity in intact cells. a-Adducin phosphorylation at Thr445
by RhoAV14 was suppressed by RB and RB/PH (TT) (Fig.
3). Constitutively active Rho-kinase (CAT) greatly induced
the a-adducin phosphorylation (Fig. 3), whereas constitu-
tively active MRCK did not (data not shown). When the
dominant active form of PKC, which activates the TPA-
responsive element linked to the chloramphenicol acetyl-
transferase reporter gene in the absence of phorbol ester
(Kaibuchi et al., 1989), was expressed, the phosphorylation
of a-adducin was not detected by anti-pT445 (Fig. 3). HA-
a-adducin-AA coexpressed with CAT was not recognized
by anti-pT445 (Fig. 3). These results indicate that a-addu-
cin was specifically phosphorylated at Thr445 via the Rho/
Rho-kinase pathway in intact cells.
Specific Phosphorylation of a-Adducin at Thr445 in the 
TPA-induced Membrane Ruffling Areas
Both Rho and Rac are thought to be necessary for the
HGF- and TPA-induced membrane ruffling and HGF-
induced cell motility in MDCK epithelial cells, although
neither RhoAV14 nor Rac1V12 by itself induces membrane
ruffling or cell motility (Takaishi et al., 1993, 1994, 1995;
Nishiyama et al., 1994; Ridley et al., 1995). We examined
the distribution of Thr445-phosphorylated a-adducin in
the TPA- or HGF-stimulated MDCK cells. We have found
by immunoblotting with isoform-specific antibodies that
120-kD a-adducin and 90-kD g-adducin (alternatively
spliced form of 80-kD g-adducin) were expressed almost
equally in MDCK cells. We have also found that 110-kD
b-adducin was expressed to a lesser extent in MDCK cells.
Therefore, it is likely that anti-pT445 recognizes only
phospho-Thr445 in a-adducin in MDCK cells. The addi-
tion of TPA induced membrane ruffling at the outer edge
of cell colonies (Fig. 4 A) as described (Nishiyama et al.,
1994; Takaishi et al., 1995). The immunoreactivity of anti-
pT445 accumulated in the membrane ruffling areas, where
F-actin (Fig. 4 A) and spectrin (data not shown) also accu-
mulated. Phosphorylated a-adducin was also detected in
the perinuclear region. Similar results were obtained when
the cells were stimulated with HGF instead of TPA (Fig. 4
A). The immunoreactivity with anti-pT445 was abolished
by preincubation of the antibody with the antigen
phosphopeptide (data not shown). In the nonstimulated
MDCK cells, phosphorylated a-adducin was diffusely
present in the cytoplasm, but not in the free ends of the
plasma membrane. Between 2 and 16 h after the addition
of TPA, the cells dissociated from each other and scat-
tered, with polarized morphology and membrane ruffling
in the leading edge as described (Takaishi et al., 1994; Rid-
ley et al., 1995). Phosphorylated a-adducin also accumu-
lated in the leading edge of TPA-induced scattering cells
(Fig. 4 A). To compare the localization of phosphorylated
a-adducin and total a-adducin, a double-label immunoflu-
orescence study was performed in MDCK cells stably ex-
pressing HA-a-adducin. Immunoreactivity showing the
distribution of HA-a-adducin (red) was detected strongly
in the cell–cell contact sites (Fig. 4 B, asterisk), weakly in
the membrane ruffling areas (Fig. 4 B, arrow), and dif-
fusely in the cytoplasm, as described (Kaiser et al., 1989;
Marrs et al., 1993). Phosphorylated a-adducin (green) was
enriched in the membrane ruffling areas in the TPA-stim-
Figure 3. The phosphorylation of a-adducin via
the Rho/Rho-kinase pathway in vivo. pEF-BOS-
HA-a-adducin (WT) (3 mg) was cotransfected
into COS7 cells with pEF-BOS vector (6 mg),
pEF-BOS encoding HA-Rac1V12 (3 mg), HA-
Cdc42V12 (3 mg), HA-RhoAV14 (3 mg), HA-
RhoAN19 (3 mg), myc-Rho-kinase (full-length) (3
mg), HA-RhoAV14 (3 mg) and myc-Rho-kinase
(full-length) (3 mg), HA-RhoAV14 (3 mg) and
myc-RB (6 mg), HA-RhoAV14 (3 mg) and myc-
RB/PH (TT) (6 mg), and myc-CAT (3 mg) or
pcDSRa-PKC (6 mg). pEF-BOS-HA-a-adducin-
AA (3 mg) was also cotransfected with myc-CAT
(3 mg). As a negative control, pEF-BOS vector
(12 mg) alone was transfected. After a 24-h incu-
bation, the transfected cells were incubated in
serum-free medium for 24 h. The lysates of the
cells were subjected to immunoblot analysis with
indicated antibodies. The amounts of the sample
in lanes of HA-a-adducin or HA-a-adducin-AA
cotransfected with CAT of the upper panel were
30% of the others. Arrowheads indicate the po-
sitions of the intact band of HA-a-adducin. The
anti-pT445–immunoreactive bands just below the intact HA-a-adducin correspond to endogenous a-adducin. The additional bands
which anti-pT445 recognized were the degradation products, because these proteins were also detected by anti-HA antibody. The ratios
of phosphorylation at Thr445 to expressed HA-a-adducin were quantitated, and the proportions relative to the ratio of CAT-induced
phosphorylation of HA-a-adducin were indicated in brackets as follows: HA-a-adducin alone, or with Rac1V12 or Cdc42V12 (0%); with
RhoAV14 (4%); with RhoAN19 (0.3%); with Rho-kinase (20%); with RhoAV14 and Rho-kinase (32%); with RhoAV14 and RB (0.1%);
with RhoAV14 and RB/PH (TT) (0%); with CAT (100%); with PKC (0%); and HA-a-adducin-AA with CAT (0%). The results are rep-
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ulated MDCK cells (Fig. 4 B, arrow). The merged image
of red and green immunofluorescence revealed the enrich-
ment of phosphorylated a-adducin in the membrane ruf-
fling areas and a small increment of phosphorylated
a-adducin in the cytoplasm in the TPA-stimulated cells
(Fig. 4 B, panel f, greenish image). Phosphorylated
a-adducin did not accumulate at the cell–cell contact sites
(Fig. 4 B, panels c and f, reddish images indicated by the
asterisks). Similar results were obtained when the cells
were stimulated with HGF. To confirm that a-adducin is
specifically phosphorylated at Thr445 during the action of
TPA, immunoblot analysis with anti-pT445 was per-
formed. The addition of TPA to the MDCK cells stably
expressing HA-a-adducin increased the phosphorylation
level of HA-a-adducin at Thr445 (Fig. 4 C).
The Inhibition of the TPA-induced Membrane
Ruffling by the Dominant Negative Rho-Kinase and
a-Adducin Mutant
We next examined whether the Rho/Rho-kinase pathway
was required for the TPA-induced membrane ruffling.
The microinjection of C3, which is thought to interfere
with endogenous Rho functions, RB, or RB/PH (TT) in-
hibited the TPA-induced membrane ruffling and the accu-
mulation of phosphorylated adducin in the free end of
the plasma membrane (Fig. 5, A and B); membrane ruf-
fling was induced in 64% of TPA-stimulated cells in the
outer edges of cell colonies, but in only 14% of cells in-
jected with C3, 15% of cells injected with RB, and 22% of
cells injected with RB/PH (TT). Dominant negative Rac
(Rac1N17) also inhibited the TPA-induced membrane ruf-
Figure 4. The localization of Thr445-phosphorylated a-adducin
in the TPA- or HGF-induced membrane ruffling. (A) The se-
rum-deprived MDCK cells were stimulated with 200 nM TPA
(panels d–f) or 50 pM HGF (panels g–i) for 15 min or with 200
nM TPA for 2 h (panels j–l). Nonstimulated (panels a–c) and
stimulated cells were doubly labeled with anti-pT445 (panels b,
e, h, and k) and TRITC-phalloidin (panels c, f, i, and l). Phase-
contrast images are shown (panels a, d, g, and j). Arrowheads indicate the induced membrane ruffling areas or the leading edges. Bar,
25 mm. (B) The enrichment of phosphorylated a-adducin in the membrane ruffling areas. MDCK cells stably expressing HA-a-adducin
were established. Nonstimulated (panels a–c) or TPA-stimulated (panels d–f) MDCK cells stably expressing HA-a-adducin were dou-
bly stained with anti-pT445 (green; panels a and d) and anti-HA (red; panels b and e). c and f show merged images of a and b, and d and
e, respectively. Arrows indicate the induced membrane ruffling areas. Asterisks indicate the cell–cell contact sites. Bar, 25 mm. (C) The
TPA-induced Thr445 phosphorylation in a-adducin. MDCK cells stably expressing HA-a-adducin were stimulated by vehicle (2) or
TPA (1) for 15 min followed by incubation in the presence of calyculin A, and then lysed and subjected to immunoblot analysis with
anti-pT445. An arrow indicates the phosphorylated HA-a-adducin. These results are representative of three independent experiments.The Journal of Cell Biology, Volume 145, 1999 354
Figure 5. The inhibition of the TPA-
induced membrane ruffling by the mu-
tants of Rho-kinase and a-adducin.
(A) The serum-deprived MDCK cells
were microinjected with MBP (2 mg/
ml; panel a), C3 (0.1 mg/ml; panel b),
GST-RB (2 mg/ml; panel c), MBP-RB/
PH (TT) (2 mg/ml; panels d and e),
or Rac1N17 (0.2 mg/ml; panel f), HA-
a-adducin (WT) (5 mg/ml; panel g),
HA-a-adducin-AA (5 mg/ml; panel h),
or HA-a-adducin-DD (5 mg/ml; panel
i) along with a marker protein (rabbit
or mouse IgG, 0.5 mg/ml). After a 30-
min incubation, the cells were stimu-
lated with 200 nM TPA for 15 min.
F-actin (panels a–d and f–i) and
Thr445-phosphorylated  a-adducin (panel
e) were visualized. Arrowheads indi-
cate the microinjected cells. Bar, 25
mm. (B) The ratios of the membrane
ruffling–induced cells to the cells in-
jected with proteins described in A are
indicated. Data are means 6 SEM of
triplicate determinations. (C) Specificity of the effect of HA-a-adducin-AA on the TPA-induced membrane ruffling. HA-a-adducin-
AA (5 mg/ml) was microinjected along with indicated proteins. The ratios of the membrane ruffling–induced cells to the injected cells
are indicated. Data are means 6 SEM of triplicate determinations. (D) HA-a-adducin-AA had no effect on stress fiber formation. The
serum-deprived NIH3T3 cells were microinjected with MBP (2 mg/ml; panel a), MBP-RB/PH (TT) (2 mg/ml; panel b), or HA-a-addu-
cin-AA (5 mg/ml; panel c). After a 30-min incubation, the cells were stimulated with 50 ng/ml LPA for 20 min. F-actin was visualized.
Arrowheads indicate the microinjected cells. Bar, 10 mm. These results are representative of three independent experiments.Fukata et al. Adducin Phosphorylation Downstream of Rho 355
fling to a similar extent (Ridley et al., 1995). These results
indicate that the Rho-kinase function is required for the
TPA-induced membrane ruffling in MDCK cells.
To determine whether the phosphorylation of adducin
by Rho-kinase is necessary or sufficient for the membrane
ruffling, we produced and used cDNAs encoding a-adducin
mutants; HA-a-adducinT445A,T480A (HA-a-adducin-AA,
substitution of Thr residues by Ala), which was not phos-
phorylated by Rho-kinase and expected to serve as the
dominant negative form, and HA-a-adducinT445D,T480D
(HA-a-adducin-DD, substitution of Thr residues by Asp),
which was expected to mimic phosphorylated a-adducin
and to serve as the constitutively active form (Sweeney et al.,
1994). The microinjection of HA-a-adducin, HA-a-addu-
cin-AA, or HA-a-adducin-DD by itself did not induce the
membrane ruffling in MDCK cells (data not shown). This
observation is consistent with the notion that RhoAV14
alone does not induce the membrane ruffling, and that a
lot of processes are required for the induction of mem-
brane ruffling. HA-a-adducin or HA-a-adducin-DD was
translocated to the membrane ruffling area (data not
shown) and did not inhibit the TPA-induced membrane
ruffling, whereas HA-a-adducin-AA inhibited the ruf-
fling; membrane ruffling was induced in z60% of TPA-
stimulated cells injected with HA-a-adducin or HA-
a-adducin-DD, but in only 24% of cells injected with
HA-a-adducin-AA (Fig. 5, A and B). Although the inhibi-
tory mechanism of HA-a-adducin-AA is not known,
HA-a-adducin-AA may substitute for endogenous
a-adducin to oligomerize with endogenous b- or g-addu-
cin, and thereby stay as an inactive complex to inhibit
functions of endogenous adducins. Essentially similar re-
sults as to the effects of RB/PH (TT) or HA-adducin-AA
on membrane ruffling were obtained when MDCK cells
were stimulated with HGF instead of TPA (data not
shown). To confirm that HA-a-adducin-AA specifically
inhibits the function of endogenous a-adducin but not
those of other substrates of Rho-kinase such as MLC or
the ERM family proteins, we examined whether the inhib-
itory effect of HA-a-adducin-AA on the membrane ruf-
fling in MDCK cells was reversed by coinjection of HA-
a-adducin or HA-a-adducin-DD. As shown in Fig. 5 C,
HA-a-adducin reversed the inhibitory effect of HA-a-addu-
cin-AA in a dose-dependent manner. HA-a-adducin-DD
more efficiently reversed the inhibitory effect. These re-
sults indicate that HA-a-adducin-AA specifically inhibits
the function of endogenous a-adducin but not those of
other substrates. When HA-a-adducin-AA was microin-
jected into NIH3T3 cells, HA-a-adducin-AA did not affect
the LPA-induced formation of stress fibers, which is medi-
ated by MLC phosphorylation through the Rho/Rho-kinase
pathway (Chihara et al., 1997; Amano et al., 1998), whereas
RB/PH (TT) inhibited the LPA-induced formation of stress
fibers as described (Amano et al., 1998; Fig. 5 D). HA-a-addu-
cin-AA did not affect the LPA-induced formation of mi-
crovilli, which is mediated by ERM phosphorylation
through the Rho/Rho-kinase pathway, under the conditions
in which RB/PH (TT) inhibited the LPA-induced formation
of microvilli (Oshiro et al., 1998; data not shown). Taken to-
gether, these results suggest that HA-a-adducin-AA specif-
ically interferes with the pathway mediated through the
a-adducin phosphorylated by Rho-kinase in intact cells.
When HA-a-adducin-DD, but not HA-a-adducin-AA,
was comicroinjected with RB or RB/PH (TT), the inhibi-
tory effect of RB or RB/PH (TT) on the TPA-induced
membrane ruffling was counteracted (Fig. 6, A and B).
Under these conditions, HA-a-adducin also counteracted
the inhibitory effect of RB/PH (TT), but not that of RB
(Fig. 6 B). This difference is likely due to the distinct mode
of action between RB and RB/PH (TT). RB/PH (TT) in-
teracts with the catalytic domain of Rho-kinase and inhib-
its the activity of Rho-kinase in a manner competitive with
peptide substrates of Rho-kinase such as RRRLSSLRA
without titrating out Rho (Amano, M., K. Chihara, N.
Nakamura, T. Kaneko, Y. Matsuura, and K. Kaibuchi,
manuscript submitted for publication). The excess of HA-
a-adducin over RB/PH (TT) in the cells may neutralize
a competitive inhibition of Rho-kinase by RB/PH (TT),
and then HA-a-adducin can be phosphorylated by the
activated Rho-kinase. Consistently, when RB/PH (TT)
was microinjected at higher concentrations, HA-a-addu-
cin could not counteract the inhibitory effect of RB/PH
(TT), whereas HA-a-adducin-DD was still capable of
counteracting (data not shown). In contrast to RB/PH
(TT), RB binds to the effector domain of Rho, and is ex-
pected to inhibit the interaction of Rho-kinase with Rho
and thereby the activation of Rho-kinase by Rho (Amano
et al., 1997). Thus, HA-a-adducin may not overcome the in-
hibitory effect of RB in MDCK cells. On the other hand,
because HA-a-adducin-DD can mimic a-adducin phos-
phorylated at Thr445 and Thr480 in vivo, HA-a-addu-
cin-DD may bypass Rho-kinase to induce membrane
ruffling during the action of TPA irrespective of the Rho-
kinase activity. HA-a-adducin-DD counteracted neither
the inhibitory effect of C3 nor that of Rac1N17 (Fig. 6, A
and B). GTPgS-bound RhoAI41, which is insensitive to C3,
could completely overcome the inhibitory effect of C3 as
described (Nishiyama et al., 1994; data not shown). Taken
together, these results indicate that HA-a-adducin-DD
serves as the constitutively active form, and that a-adducin
is a crucial substrate of Rho-kinase downstream of Rho
for membrane ruffling.
Adducin Phosphorylation via the Rho/Rho-Kinase 
Pathway and Cell Motility
Membrane ruffling is thought to be an essential event in
cell motility (Mitchison and Cramer, 1996). We then inves-
tigated whether the a-adducin phosphorylation by Rho-
kinase is involved in cell motility. C3 has been shown to in-
hibit the wound-induced migration of IEC-6 cells (Santos
et al., 1997). We performed a wound healing assay by the
use of NRK49F cells to investigate roles of Rho-kinase
and adducin in cell motility, since it was difficult to es-
timate the precise distance moved in MDCK cells and to
evaluate cell motility induced by TPA or HGF, and
NRK49F cells were more suitable for a wound healing as-
say than were MDCK cells. Linear wounds were made in a
confluent monolayer of NRK49F cells and z200 cells
along the wound edge were microinjected with C3, RB/PH
(TT), or the a-adducin mutants. 6 h after wounding, the
cells that moved (.20 mm) from the original wound edge
were counted. We also evaluated the wound-induced mi-
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jected as a control protein, 63% of the total injected cells
showed wound-oriented migration, and z60% of the total
injected cells had membrane rufflings (Fig. 7, B and C).
About 90% of the migrating injected cells had membrane
rufflings in their leading edges (Fig. 7 B). We found that
a-adducin phosphorylated at Thr445 accumulated at the
membrane ruffling areas in the leading edge and the peri-
nuclear region in migrating NRK49F cells (Fig. 7 A), as
shown in MDCK cells. C3 and RB/PH (TT) inhibited the
migration to the wound; only 24% of cells injected with C3
and 17% of cells injected with RB/PH (TT) migrated to
the wound (Fig. 7, B and C). The microinjection of HA-
a-adducin-AA also inhibited the migration; only 21% of
cells injected with HA-a-adducin-AA migrated to the wound
(Fig. 7, B and C). When C3, RB/PH (TT), or a-adducin-
AA was injected, the percentages of the cells with mem-
brane ruffling in the total injected cells (z20%) were
roughly the same as those of the migrating cells in the total
injected cells (17–24%), and the stationary injected cells
had few membrane rufflings (Fig. 7 B). Whatever proteins
were injected, the majority (z90%) of migrating injected
cells had membrane ruffling in the leading edge. These
results suggest that the inhibition of cell migration by HA-
a-adducin-AA, C3, or RB/PH (TT) correlates with the
inhibition of membrane ruffling. In the HA-a-adducin–
injected cells, the wound-oriented migration and membrane
ruffling were not inhibited (Fig. 7, B and C). HA-a-addu-
cin-DD also inhibited the migration; 32% of cells injected
with HA-a-adducin-DD migrated to the wound (Fig. 7, B
and C). However, the percentage of the cells with mem-
brane ruffling in the total injected cells (z60%) was much
bigger than that of the migrating cells in the total injected
cells (32%). The majority of migrating cells injected with
a-adducin-DD had membrane rufflings in the leading
edge, and about one-half of the stationary cells injected
with a-adducin-DD had membrane rufflings (Fig. 7 B,
panel k). These results indicate that a-adducin-DD did not
inhibit the membrane ruffling but did inhibit cell migra-
tion, suggesting that cycling between the phosphorylated
and dephosphorylated states of a-adducin appears to be
necessary for cell migration, but not for membrane ruf-
fling. Consistently, RhoAV14 or CAT as well as Rac1N17 in-
hibited the wound-induced migration (data not shown).
Discussion
Phosphorylation Sites of a-Adducin by Rho-Kinase and 
Site- and Phosphorylation State–specific Antibodies
In this study, we identified the sites of phosphorylation of
a-adducin by Rho-kinase as Thr445 and Thr480 in the
neck domain. a-Adducin is phosphorylated at Ser408,
Ser436, and Ser481 in the neck domain by PKA, and at
Ser726 in the MARCKS-related domain by PKC and PKA
(Matsuoka et al., 1996). Among the in vitro phosphory-
lation sites of a-adducin, Thr445 and Thr480 are unique
for Rho-kinase. We raised and used a site- and phosphory-
lation state–specific antibody for a-adducin. Anti-pT445
recognized HA-a-adducin phosphorylated by Rho-
kinase, but not by PKC or PKN. Anti-pT445 recog-
Figure 6. Effects of a-adducin mutants on the membrane ruffling in the cells introduced with the dominant negative Rho-kinase. MBP,
HA-a-adducin (WT), HA-a-adducin-AA, or HA-a-adducin-DD (10 mg/ml) was comicroinjected with C3 (0.1 mg/ml), GST-RB (2 mg/
ml), MBP-RB/PH (TT) (2 mg/ml), or Rac1N17 (0.2 mg/ml) along with a marker protein (rabbit IgG, 0.5 mg/ml) into the serum-deprived
MDCK cells. After a 30-min incubation, the cells were stimulated with 200 nM TPA for 15 min. (A) The cells into which HA-a-addu-
cin-DD was comicroinjected with GST-RB (panels a and b), MBP-RB/PH (TT) (panels c and d), and Rac1N17 (panels e and f) are
shown. The cells were doubly labeled with TRITC-phalloidin (panels a, c, and e) and FITC anti–rabbit Ig Ab (panels b, d, and f). Ar-
rowheads indicate the microinjected cells. Bar, 25 mm. These results are representative of three independent experiments. (B) The ra-
tios of the membrane ruffling–induced cells to injected cells are indicated. Data are means 6 SEM of triplicate determinations.Fukata et al. Adducin Phosphorylation Downstream of Rho 357
Figure 7. Effects of the mutants of Rho-kinase and a-adducin on cell migration in a wound healing assay. (A) The localization of
Thr445-phosphorylated a-adducin in the migrating NRK49F cell. NRK49F cells which migrated in response to the wounding were
stained with TRITC-phalloidin (panel a) and anti-pT445 (panel b). Arrows indicate the direction of migration. Arrowheads indicate the
membrane ruffling in the leading edge. Bar, 20 mm. (B) A confluent monolayer of NRK49F cells was linearly wounded with a white
chip. Soon after wounding, MBP (5 mg/ml; panels a and b), C3 (0.1 mg/ml; panels c and d), MBP-RB/PH (TT) (5 mg/ml; panels e and f),
HA-a-adducin (WT) (5 mg/ml; panels g and h), HA-a-adducin-AA (5 mg/ml; panels i and j), or HA-a-adducin-DD (5 mg/ml; panels k
and l) was microinjected along with a marker protein (rabbit IgG, 1.0 mg/ml) into the cytoplasm of only the cells along the wound edge.
The original wound edge was determined by taking photographs soon after the cells were wounded and microinjected, and then the
cells that moved (.20 mm) from the original wound edge were counted by taking photographs of the same fields after 6 h. The cells
were doubly labeled by staining with TRITC-phalloidin (panels a, c, e, g, i, and k) and FITC anti–rabbit Ig Ab (panels b, d, f, h, j, and l).
Arrows indicate the positions of the migrating wound edge cells. Arrowheads indicate the injected cells. Morphologies of the injected
cells that showed the typical phenotypes were shown in insets. Bar, 20 mm. These results are representative of three independent exper-
iments. (C) The ratios of migrating cells to the total injected cells are indicated. Data are means 6 SEM of triplicate determinations.The Journal of Cell Biology, Volume 145, 1999 358
nized neither nonphosphorylated HA-a-adducin nor HA-
a-adducinT445A,T480A incubated with Rho-kinase and ATP
(Fig. 2 A). These results indicate that anti-pT445 is a use-
ful tool with which to detect the specific phosphorylation
of a-adducin by Rho-kinase both in vitro and in vivo, dis-
tinguishing from the phosphorylation of a-adducin by
PKC. Although Rho-kinase phosphorylated b- and g-addu-
cin in vitro (Fig. 2 B), the phosphorylation sites have not
been determined. Since the surrounding amino acid se-
quences of Thr437 in rat g-adducin (QQREKTRWLNS)
are completely identical to those of Thr445 in a-adducin
(selected as antigen phosphopeptide for anti-pT445), the
result that anti-pT445 did not cross-react with rat g-addu-
cin phosphorylated by Rho-kinase (Fig. 2 B) revealed that
Rho-kinase does not primarily phosphorylate g-adducin at
Thr437. The surrounding amino acid sequences of Thr431
in b-adducin (QQKEKTRWLNT) are a little bit different
from those of Thr445 in a-adducin. At this stage, we do
not know whether Rho-kinase phosphorylates b-adducin
at Thr431. Adducin is thought to be comprised of a- and
b-, or a- and g-adducin in vivo (Bennett et al., 1988; Dong
et al., 1995). We found that in MDCK and NRK49F cells a
heterodimer of adducin which consists of a- and g-adducin
was mainly expressed (data not shown). Therefore, it is
likely that anti-pT445 recognizes only phospho-Thr445 in
a-adducin but not in b- and g-adducin in both cells (see
below). Further analysis is necessary to understand how
the phosphorylation of b- or g-adducin is regulated through
Rho-kinase in vitro and in vivo.
In Vivo Phosphorylation of a-Adducin via the
Rho/Rho-Kinase Pathway
Using anti-pT445, we found that Thr445 phosphorylation
of  a-adducin occurred in a Rho/Rho-kinase-dependent
manner in COS7 cells (Fig. 3). We further found that
a-adducin was phosphorylated at Thr445 in the TPA-stim-
ulated MDCK cells (Fig. 4 C). TPA also drives the activa-
tion of PKC. Indeed, TPA induces the phosphorylation of
a-adducin at Ser726 in renal proximal tubule epithelial
cells and MDCK cells (Fowler et al., 1998; Matsuoka et al.,
1998). However, it is unlikely that PKC directly phos-
phorylates a-adducin at Thr445 in the TPA-stimulated
cells, because anti-pT445 did not recognize a-adducin
which was phosphorylated by PKC in vitro and was coex-
pressed with the dominant active PKC in COS7 cells. Rac
and Cdc42 are also involved in TPA-induced phenomena
such as membrane ruffling (Ridley et al., 1995). It is possi-
ble that the protein kinases activated by Rac or Cdc42
phosphorylate  a-adducin. However, we found that neither
Rac1V12 nor Cdc42V12 induced the Thr445 phosphorylation
of a-adducin in COS7 cells, and that the dominant active
MRCK, which is identified as the target of Cdc42 (Leung
et al., 1998) and Rac1 (Nakamura, N., M. Amano, Y.
Fukata, N. Oshiro, T. Leung, L. Lim, and K. Kaibuchi,
manuscript in preparation), induced the phosphorylation
of MLC but not of a-adducin at Thr445. Taken together,
these results indicate that in intact cells a-adducin was spe-
cifically phosphorylated at Thr445 via the Rho/Rho-kinase
pathway during the action of TPA. Although an in
vitro experiment using GST-a-adducinT445A and GST-
a-adducinT480A (Fig. 1 D) suggests that Thr445 is a prefer-
ential site of phosphorylation by Rho-kinase in vitro, at
this stage it is unknown which of Thr445 or Thr480 is a
preferential site in intact cells.
Involvement of the Phosphorylation of a-Adducin via 
the Rho/Rho-Kinase Pathway in Membrane Ruffling 
and Cell Motility
Membrane ruffling, which is induced by several growth
factors and is observed in the leading edges of motile cells,
is thought to play an essential role in cell motility. The reg-
ulatory mechanism of the membrane ruffling is less well
characterized. Not only Rac but also Rho is thought to
regulate the membrane ruffling downstream of extracellu-
lar signals in certain types of cells, because C3 inhibits the
TPA- or HGF-induced membrane ruffling in epithelial
cells such as MDCK and KB cells (Nishiyama et al., 1994;
Takaishi et al., 1995). Here, we found that Thr445-phos-
phorylated a-adducin accumulated at the TPA-induced
membrane ruffling areas and the leading edges of migrat-
ing cells (Figs. 4 and 7 A). We furthermore found that RB
and RB/PH (TT) as well as C3 inhibited the TPA-induced
membrane ruffling, that a-adducin-AA also inhibited the
membrane ruffling as the dominant negative a-adducin
(Fig. 5, A and B), and that a-adducin-DD specifically
counteracted the inhibitory effect of RB and RB/PH (TT)
on the membrane ruffling (Fig. 6). These results indicate
that a-adducin is a crucial substrate of Rho-kinase down-
stream of Rho for membrane ruffling. The fact that
a-adducin-DD counteracted the inhibitory effect of RB
but not that of C3 (Fig. 6 B) is probably due to difference
between the inhibitory mechanisms by RB and C3. RB is
the fragment of Rho-kinase which consists of the RB do-
main of Rho-kinase. RB binds to the effector domain of
Rho, and then inhibits the interaction of Rho with Rho-kinase
(Amano et al., 1997). Recent studies revealed that the var-
ious effector mutants of RhoAV14, in which interaction
with some effectors is maintained but with others is lost,
make it possible to dissect the diverged pathways down-
stream of Rho. For example, RhoAY42C abolishes interac-
tion with PKN but maintains interaction with ROCK-I (an
isoform of Rho-kinase) and RhoAF39L,C20R maintains in-
teraction with PKN but abolishes interaction with ROCK-
I (Sahai et al., 1998). RhoAY42C induces stress fiber forma-
tion, whereas RhoAF39L,C20R does not induce stress fiber
formation, suggesting that ROCK-I but not PKN is re-
quired for stress fiber formation. These observations indi-
cate that there are distinct interfaces in the effector do-
main of Rho for the different classes of effector proteins.
Although at this time we cannot completely rule out the
possibility that RB inhibits interaction of Rho with the
other Rho targets such as PKN and p140mDia, RB may in-
hibit preferentially the interaction of Rho with Rho-kinase
rather than with other Rho targets. On the other hand, C3
interferes with the whole functions of Rho. In fact, C3 in-
hibits the activity of PKN as well as Rho-kinase in Swiss 3T3
cells (Amano et al., 1996) and the Rho-dependent recruitment
of p140mDia to the dynamic membrane structures in Swiss
3T3 cells (Watanabe et al., 1997). C3 may inhibit the mem-
brane ruffling by impairing the whole functions of Rho,
whereas RB may inhibit the membrane ruffling by mainly
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We also found that not only C3 and RB/PH (TT) but
also a-adducin-AA inhibited cell motility as well as mem-
brane ruffling in NRK fibroblasts (Fig. 7, B and C). This
suggests that a-adducin is one of the substrates for Rho-
kinase involved in cell motility, probably regulating the
membrane ruffling in the leading edges of motile cells. As
for the substrates of Rho-kinase, MLC is another major
substrate which is thought to play an important role in cell
motility. Indeed, injection of anti-MLC kinase antibody
diminishes the cell motility of macrophages (Wilson et al.,
1991). Moreover, phosphorylated MLC is enriched in both
the leading edges and rear ends of motile fibroblasts and
epithelial cells (Matsumura et al., 1998), suggesting that a
force derived from myosin-actin filament driven by the
MLC phosphorylation contributes to cell motility. Thus,
Rho, acting through Rho-kinase, appears to regulate cell
motility through the spatial and temporal regulation of
phosphorylation of certain substrates including adducin
and MLC.
It should be noted that in Swiss 3T3 or NIH3T3 fibro-
blasts, in which the dominant active Rac by itself is suffi-
cient to induce the membrane ruffling (Hall, 1998), a-addu-
cin phosphorylated at Thr445 was not observed in the
dominant active Rac-induced ruffling areas, and neither
C3, RB/PH (TT), nor HA-a-adducin-AA inhibited the
dominant active Rac-induced ruffling (data not shown).
On the other hand, we found that in KB epithelial cells as
well as MDCK epithelial cells, a-adducin phosphorylated
at Thr445 accumulated in the TPA-induced membrane
ruffling areas, and that C3 and RB/PH (TT) inhibited the
TPA-induced membrane ruffling (data not shown). When
RB/PH (TT) or a-adducin-AA was injected to MDCK
cells, the HGF-induced membrane ruffling was also inhib-
ited as the TPA-induced membrane ruffling (data not
shown). The regulatory system of the membrane ruffling
may vary among cell types. It is conceivable that the mem-
brane ruffling in a certain type of cell such as MDCK epi-
thelial cells may require not only the Rac-mediated path-
way but also the phosphorylation of adducin by the Rho/
Rho-kinase pathway, whereas that in other types of cells
such as Swiss 3T3 fibroblasts may require only the Rac-
mediated pathway. Further studies are necessary to deter-
mine what causes the differences between the two types of
cell lines.
Regulation of a-Adducin Function through 
Phosphorylation by Rho-Kinase and PKC
These results indicate that the phosphorylation of a-addu-
cin by the Rho/Rho-kinase pathway plays a crucial role in
the regulation of membrane ruffling and cell motility.
What is the function of the a-adducin phosphorylation in
membrane ruffling and cell motility? Membrane ruffles
contain complicated cytoskeletal structures composed of
F-actin and other F-actin–associated proteins (Mitchison
and Cramer, 1996). Spectrin, which binds to F-actin be-
neath plasma membrane and forms a membrane cortical
meshwork, also accumulates at the leading edges of motile
cells (Burridge et al., 1982; Sormunen and Lehto, 1995).
This lattice-like meshwork is dynamically reconstructed
and required for the formation of membrane ruffling
(Lauffenburger and Horwitz, 1996). Since the phosphory-
lation of a-adducin by Rho-kinase is known to promote
the binding of a-adducin to F-actin (Kimura et al., 1998)
and this in turn induces the recruitment of spectrin to
F-actin (Gardner and Bennett, 1987; Bennett et al., 1988),
it is possible that the formation of a spectrin-F-actin mesh-
work is dynamically regulated in the active membrane ruf-
fling by the Rho/Rho-kinase pathway (Fig. 8). It is also
possible that Rho-kinase modulates the F-actin–capping
activity (Li et al., 1998) or cross-linking activity (Mische et al.,
1987) of adducin and then regulates actin dynamics in the
membrane ruffling areas. Adducin is also a substrate of
PKC, which is activated in response to TPA or HGF, and
the phosphorylation of a-adducin by PKC inhibits the ac-
tivity of adducin in promoting the formation of a spectrin–
actin complex in vitro (Matsuoka et al., 1998). TPA in-
duces the phosphorylation of a-adducin at Ser726 and the
redistribution of a-adducin phosphorylated at Ser726 from
the cell membrane to cytoplasm accompanied by that of
spectrin in renal proximal tubule epithelial and MDCK
cells (Fowler et al., 1998; Matsuoka et al., 1998). Interest-
Figure 8. Model for the role
of adducin phosphorylated
by the Rho/Rho-kinase path-
way in cell motility. A spec-
trin-F-actin meshwork is
linked to the plasma mem-
brane by association with
membrane accessory pro-
teins such as band 4.1. Upon
the activation of Rho-kinase
by Rho during the action of
extracellular stimuli, a-addu-
cin is phosphorylated at
Thr445 and Thr480. Phos-
phorylated a-adducin binds
to F-actin, and then facili-
tates the recruitment of spec-
trin to F-actin. This may promote the formation of a spectrin-F-actin meshwork beneath plasma membrane for membrane ruffling. On
the other hand, PKC phosphorylates a-adducin at Ser726, and then inhibits the activity of adducin in recruiting spectrin to F-actin. This
may in turn induce the disassembly of a spectrin-F-actin meshwork. Transition between the phosphorylation states of a-adducin by
Rho-kinase and PKC may regulate the remodeling of membrane ruffling, which is important for cell migration.The Journal of Cell Biology, Volume 145, 1999 360
ingly,  a-adducin phosphorylated at Ser726 was also ob-
served in the membrane ruffling areas (Matsuoka, Y., and
V. Bennett, manuscript in preparation). It is conceivable
that a-adducin phosphorylated by PKC dissociates from
a spectrin-F-actin meshwork during membrane ruffling.
Thus, it is tempting to speculate that the adducin function
may be cyclically regulated through the phosphorylation
by Rho-kinase and PKC during the action of TPA or HGF,
and the alternative phosphorylation contributes to the
turnover of a spectrin-F-actin meshwork for membrane ruf-
fling. In this regard, it is interesting that a-adducin-DD
inhibits the wound-induced migration of NRK49F cells
but not their membrane ruffling. This suggests that the
“on” and “off” states of a-adducin are necessary for cell mi-
gration (Fig. 8).
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Note Added in Proof: After we submitted this paper, it was reported that
the GTPase cycle of Rho was important for cell migration in a wound
healing assay (Nobes, C.D., and A. Hall. 1999. Rho GTPases control po-
larity, protrusion, and adhesion during cell movement. J. Cell Biol. 144:
1235–1244).
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